Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-04-22
2010-10-26
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S422000, C514S428000, C514S429000, C548S527000, C548S574000, C548S577000, C544S141000
Reexamination Certificate
active
07820661
ABSTRACT:
Therapeutic compounds, compositions, medicaments, and methods are disclosed herein.
REFERENCES:
patent: 3985798 (1976-10-01), Floyd, Jr. et al.
patent: 4007210 (1977-02-01), Bernady
patent: 4060540 (1977-11-01), Bernady
patent: 4166452 (1979-09-01), Generales
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen
patent: 4994274 (1991-02-01), Chan
patent: 5028624 (1991-07-01), Chan
patent: 5034413 (1991-07-01), Chan
patent: 5446041 (1995-08-01), Chan
patent: 6437146 (2002-08-01), Hattori
patent: 6531614 (2003-03-01), Conrow
patent: 6573294 (2003-06-01), Old
patent: 6710072 (2004-03-01), Burk
patent: 7091231 (2006-08-01), Donde
patent: 7473704 (2009-01-01), Old
patent: 7476747 (2009-01-01), Old
patent: 2003/0120079 (2003-06-01), Elworthy
patent: 2006/0205800 (2006-09-01), Donde
patent: 2007/0203222 (2007-08-01), Old
patent: 2007/0219265 (2007-09-01), Old
patent: 2007/0265330 (2007-11-01), Old
patent: 2008/0039505 (2008-02-01), Old
patent: 2008/0269498 (2008-10-01), Old
patent: 2009/0286787 (2009-11-01), Old et al.
patent: 0308135 (1989-03-01), None
patent: WO 93/014743 (1993-08-01), None
patent: WO 95/19964 (1995-07-01), None
patent: WO 03/103604 (2003-12-01), None
patent: WO 2004/037813 (2004-05-01), None
patent: WO 2006/098918 (2006-09-01), None
patent: WO 2007/109578 (2007-09-01), None
patent: WO 2007/005176 (2007-11-01), None
patent: WO 2008/064039 (2008-05-01), None
U.S. Appl. No. 12/524,803, filed Jul. 2009, Old et al.
U.S. Appl. No. 12/323,077, filed Nov. 25, 2008, Old.
Bernady et al., 1977, CAS: 87:22543.
Bito, L.Z. Arch. Ophthalmol. Prostaglandins, Old Concepts and New Perspectives, vol. 105, pp. 1036-1039 (1987).
Bito, L.Z., Biological Protection with Prostaglandins, “Prostaglandins and Related Compounds as Potential Ocular Therapeutic Agents”, vol. 1, Chapter 18, 1985, pp. 231-252.
Bito, L.Z., Glaucoma, Applied Pharmacology in the Medical Treatment, “Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents”, 1984, Chapter 20, pp. 477-505.
Brawner et al. Prostaglandins and Congeners. 21. Synthesis of Some Cyclohexyl Analogs. XP002310257, Journal of Organic Chemistry, 44(1), 71-75, 1979.
Carey, Francis A.: Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Casy et al. Methyl 7-Hydroxyhept-5-Ynoate, Organic Synthesis, 415-420.
Crossley et al. Cyclohexane Analogs of the Prostaglandins. XP002310260, Tetrahedron Letters, (36), 3327-3330, 1971.
Kwon et al., Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism from Industrial Scientists, 2001, http://www.my.ilibrary.com/Browse/open.asp?ID=4284&loc=1, Retrieved from the Internet Jun. 16, 2008, p. 213.
Hareau et al, Synthesis of Optically Active 5-(Tert-Butyldimethylsiloxy)-2-Cyclohexenone and Its 6-Substituted Derivatives as Useful Chiral Building Blocks for the Synthesis of Cyclohexane Rings. Syntheses of Carone, Penienone, and Penihydrone, J. Am. Chem. Soc. 1999, 121, 3640-3650.
Lopez-Pelegrin et al, Solution- and Soluble-Polymer Supported Asymmetric Synthesis of Six-Membered Ring Prostanoids, Chem. Eur. J. 2000, 6, 1917-1922.
Metabolomics [Online], Retrieved from the Internet Jun. 16, 2008, www.en.wikipedia.org/wiki/Metabolomics.
Nilsson et al., Invest. Ophthalmol. Vis. Sci. (Suppl), 284 (1987), Arvo Abstracts 9-6:00.
Ohuchida et al. Synthesis of Thromboxane A2 Analogs-3. (+)-Thiathromboxane A2. XP002310259, Tetrahedron, 39(4), 4269-4272, 1983.
Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, PA., 16thEdition, 1980.
Siebold et al, Prodrug 5 3, Esterified Protaglandin Shows ‘potent’ Promise, 1989.
Stella, Valentino J. Expert Opinion of Therapeutic Patents, Prodrugs as Therapeutics, 2004 14(3):277-280.
Wolff et al., Burger's Medicinal Chemistry and Drug Discovery, 1994, Wiley-Interscience, Fifth Edition, vol. 1: Principles and Practice, pp. 975-977.
Resul, Bahram; et al.: Structure-Activity Relationships of Prostaglandin Analogues as Ocular Hypotensive Agents. Current Opinion in Therapeutic Patents, vol. 3, No. 6, Jan. 1, 1993, pp. 781-795.
Dinh Danny T.
Old David W.
Allergan Inc.
Barker Michael
Ene Doina G.
Forrestal Kevin J.
Saeed Kamal A
LandOfFree
Substituted gamma lactams as therapeutics agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted gamma lactams as therapeutics agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted gamma lactams as therapeutics agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176790